NICE looks set to back ‘triple therapy’ diabetes drug

The National Institute for Health and Care Excellence has provisionally recommended dapagliflozin for treating type 2 diabetes in “triple therapy”.
Source: Nursing Times - Category: Nursing Source Type: news